Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma - 5-Year results from the collaborative ocular melanoma study: COMS QOLS report no. 3

Archives of Ophthalmology

Volumn 124, Issue 2, 2006, Pages 226-238

  Melia, Michele ^a  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ADULT; AGED; ANXIETY; ARTICLE; BINOCULAR VISION; BRACHYTHERAPY; CANCER RECURRENCE; CHOROID MELANOMA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COURSE EVALUATION; DAILY LIFE ACTIVITY; DEPRESSION; DRIVING ABILITY; ENUCLEATION; EYE PAIN; FEMALE; FOLLOW UP; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT SATISFACTION; PERIPHERAL VISION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SHORT FORM 36; STEREOSCOPIC VISION; VISUAL ACUITY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; AUTOMOBILE DRIVING; BRACHYTHERAPY; CHOROID NEOPLASMS; DEPRESSION; DEPTH PERCEPTION; EYE ENUCLEATION; FEMALE; HEALTH STATUS; HUMANS; IODINE RADIOISOTOPES; MALE; MELANOMA; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SICKNESS IMPACT PROFILE; VISION, BINOCULAR;

EID: 32644458173     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.2.226     Document Type: Article

References (36)

1. Collaborative Ocular Melanoma Study Group. COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol. 2001;119:969-982.
2. Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS Report No. 3. Control Clin Trials. 1993;14:362-391.
3. Collaborative Ocular Melanoma Study. COMS Manual of Procedures January 1995. Springfield, Va: National Technical Information Service; 1995. #PB95-179693.
4. COMS Quality of Life Study Group. Quality of life assessment in the Collaborative Ocular Melanoma Study: design and methods. COMS-QOLS Report No. 1. Ophthalmic Epidemiol. 1999;6:5-17.
5. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey. Med Care. 1988;26:724-735.
6. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care. 1992;30:473-483.
7. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, Mass: Health Institute, New England Medical Center; 1993.
8. Mangione CM, Phillips RS, Seddon JM, et al. Development of the "Activities of Daily Vision Scale": a measure of visual functional status. Med Care. 1992;30:1111-1126.
9. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-Item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050-1058.
10. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370.
11. Collaborative Ocular Melanoma Study - Quality of Life Study Group. Development and validation of disease-specific measures for choroidal melanoma: COMS-QOLS Report No. 2. Arch Ophthalmol. 2003;121:1010-1020.
12. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
14. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. New York, NY: Oxford University Press Inc; 1994:87.
15. Hillis A, Maguire M, Hawkins BS, Newhouse MM. The Markov process as a general method for nonparametric analysis of right-censored medical data. J Chronic Dis. 1986;39:595-604.
16. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
17. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17. Arch Ophthalmol. 2001;119:951-965.
18. Collaborative Ocular Melanoma Study Group. Collaborative Ocular Melanoma Study (COMS) randomized trial of i-125 brachytherapy for medium choroidal melanoma, I: visual acuity after 3 years: COMS Report No. 16. Ophthalmology. 2001;108:348-366.
19. Jampol LM, Moy CS, Murray TG, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, IV: local treatment failure and enucleation in the first 5 years after brachytherapy. COMS Report No. 19. Ophthalmology. 2002;109:2197-2206.
20. Javitt JC, Brenner MH, Curbow B, et al. Outcomes of cataract surgery: improvement in visual acuity and subjective visual function after surgery in the first, second, and both eyes. Arch Ophthalmol. 1993;111:686-691.
21. Mangione CM, Phillips RS, Lawrence MG, et al. Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol. 1994;112:1419-1425.
22. Brown GC. Vision and quality-of-life. Trans Am Ophthalmol Soc. 1999;97:473-511.
23. Castells X, Alonso J, Ribo C, et al. Comparison of the results of first and second cataract eye surgery. Ophthalmology. 1999;106:676-682.
24. Brown MM, Brown GC, Sharma S, et al. Quality of life associated with unilateral and bilateral good vision. Ophthalmology. 2001;108:643-648.
25. Mendes F, Schaumberg DA, Navon S, et al. Assessment of visual function after corneal transplantation: the quality of life and psychometric assessment after corneal transplantation (Q-PACT) study. Am J Ophthalmol. 2003;135:785-793.
26. Mangione CM, Gutierrez PR, Lowe G, et al. Influence of age-related maculopathy on visual functioning and health-related quality of life. Am J Ophthalmol. 1999;128:45-53.
27. Brody BL, Gamst AC, Williams RA, et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108:1893-1901.
28. Broman AT, Munoz B, Rodriguez J, et al. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci. 2002;43:3393-3398.
29. Clemons TE, Chew EY, Bressler SB, McBee W; AREDS Research Group. National Eye Institute Visual Function Questionnaire in the Age-related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol. 2003;121:211-217.
30. Cruickshanks KJ, Fryback DG, Nondahl DM, et al. Treatment choice and quality of life in patients with choroidal melanoma. Arch Ophthalmol. 1999;117:461-467.
31. Manschot WA, Lee WR, van Strik R. Uveal melanoma: updated considerations on current management modalities. Int Ophthalmol. 1996;19:203-209.
32. Damato B. Disease and "dis-ease" in patients with uveal melanoma. Br J Ophthalmol. 2000;84:343-344.
33. Reimer J, Esser J, Fleiss A, et al. Quality of life in patients with malignant choroidal melanoma after radiotherapy. Graefes Arch Clin Exp Ophthalmol. 2003;241:371-377.
34. Brandberg Y, Kock E, Oskar K, af Trampe E, Seregard S. Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study. Eye. 2000;14:839-846.
35. Lasry JC, Margolese RG. Fear of recurrence, breast-conserving surgery, and the trade-off hypothesis. Cancer. 1992;69:2111-2115.
36. Campbell BH, Marbella A, Layde PM. Quality of life and recurrence concern in survivors of head and neck cancer. Laryngoscope. 2000;110:895-906.